company background image
RSLB.F logo

RaySearch Laboratories OTCPK:RSLB.F Stock Report

Last Price

US$19.09

Market Cap

US$649.0m

7D

0%

1Y

n/a

Updated

27 Dec, 2024

Data

Company Financials +

RaySearch Laboratories AB (publ)

OTCPK:RSLB.F Stock Report

Market Cap: US$649.0m

RSLB.F Stock Overview

A medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. More details

RSLB.F fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance6/6
Financial Health6/6
Dividends0/6

Rewards

Price-To-Earnings ratio (40.7x) is below the Healthcare Services industry average (58.5x)

Earnings are forecast to grow 24.14% per year

Earnings grew by 172.8% over the past year

Risk Analysis

Shares are highly illiquid


My Notes

Capture your thoughts, links and company narrative

RaySearch Laboratories AB (publ) Competitors

Simulations Plus

NasdaqGS:SLP

US$577.5m

HealthStream

NasdaqGS:HSTM

US$974.8m

Doximity

NYSE:DOCS

US$10.9b

OneMedNet

NasdaqCM:ONMD

US$38.6m

Price History & Performance

Summary of share price highs, lows and changes for RaySearch Laboratories
Historical stock prices
Current Share PriceSEK 19.09
52 Week HighSEK 19.09
52 Week LowSEK 8.33
Beta1.34
1 Month Change6.06%
3 Month Changen/a
1 Year Changen/a
3 Year Change190.56%
5 Year Change71.06%
Change since IPO767.73%

Recent News & Updates

Recent updates

Shareholder Returns

RSLB.FUS Healthcare ServicesUS Market
7D0%-1.9%0.6%
1Yn/a-1.3%23.8%

Return vs Industry: Insufficient data to determine how RSLB.F performed against the US Healthcare Services industry.

Return vs Market: Insufficient data to determine how RSLB.F performed against the US Market.

Price Volatility

Is RSLB.F's price volatile compared to industry and market?
RSLB.F volatility
RSLB.F Average Weekly Movementn/a
Healthcare Services Industry Average Movement9.8%
Market Average Movement6.3%
10% most volatile stocks in US Market17.6%
10% least volatile stocks in US Market3.1%

Stable Share Price: RSLB.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine RSLB.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1988414Johan Lofwww.raysearchlabs.com

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research.

RaySearch Laboratories AB (publ) Fundamentals Summary

How do RaySearch Laboratories's earnings and revenue compare to its market cap?
RSLB.F fundamental statistics
Market capUS$649.04m
Earnings (TTM)US$15.93m
Revenue (TTM)US$106.40m

40.7x

P/E Ratio

6.1x

P/S Ratio

Is RSLB.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RSLB.F income statement (TTM)
RevenueSEK 1.17b
Cost of RevenueSEK 104.50m
Gross ProfitSEK 1.06b
Other ExpensesSEK 889.45m
EarningsSEK 175.06m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 21, 2025

Earnings per share (EPS)5.11
Gross Margin91.06%
Net Profit Margin14.97%
Debt/Equity Ratio0%

How did RSLB.F perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

14%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 04:48
End of Day Share Price 2024/12/05 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RaySearch Laboratories AB (publ) is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Hans MählerDNB Markets
Hans MählerHandelsbanken Capital Markets